Lee; Wen-Cherng
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lee; Wen-Cherng.The latest application filed is for "isoindoline derivative, pharmaceutical composition and use thereof".
Company Profile
6.27.41
- Lee; Wen-Cherng - Shanghai CN
- LEE; Wen-Cherng - Lexington MA
- LEE; Wen-Cherng - Pudong New Area Shanghi
Patent Activity
| Patent | Date |
|---|---|
| Isoindoline derivative, pharmaceutical composition and use thereof Grant 11,337,964 - Lee , et al. May 24, 2 | 2022-05-24 |
| Isoindoline Derivative, Pharmaceutical Composition And Use Thereof App 20220152002 - Lee; Wen-Cherng ; et al. | 2022-05-19 |
| Combination Treating Prostate Cancer, Pharmaceutical Composition And Treatment Method App 20210267946 - GE; Chuansheng ; et al. | 2021-09-02 |
| Quinazolinone Derivative, Preparation Method Therefor, Pharmaceutical Composition, And Applications App 20210206743 - LEE; Wen-Cherng ; et al. | 2021-07-08 |
| Quinazolinone derivative, preparation method therefor, pharmaceutical composition, and applications Grant 11,001,566 - Lee , et al. May 11, 2 | 2021-05-11 |
| Pharmaceutical Composition Comprising a Benzoheterocyclic Compound and Androgen Receptor Pathway Modulator and Application Thereof App 20210113545 - GE; Chuansheng ; et al. | 2021-04-22 |
| Heterocyclic Compounds Useful As Pdk1 Inhibitors App 20210070752 - ARNDT; Joseph ; et al. | 2021-03-11 |
| Combination, application thereof and treatment method Grant 10,933,059 - Ge , et al. March 2, 2 | 2021-03-02 |
| Novel Isoindoline Derivative, A Pharmaceutical Composition And Use Thereof App 20200061033 - Lee; Wen-Cherng ; et al. | 2020-02-27 |
| Quinazolinone Derivative, Preparation Method Therefore, Pharmaceutical Composition, And Applications App 20200039950 - LEE; Wen-Cherng ; et al. | 2020-02-06 |
| Combination Treating Prostate Cancer, Pharmaceutical Composition And Treatment Method App 20200000776 - GE; Chuansheng ; et al. | 2020-01-02 |
| Combination, Application Thereof And Treatment Method App 20190328722 - GE; Chuansheng ; et al. | 2019-10-31 |
| Heterocyclic Compounds Useful As Pdk1 Inhibitors App 20190119268 - ARNDT; Joseph ; et al. | 2019-04-25 |
| Methods Of Treatment Using Pyridinonyl Pdk1 Inhibitors App 20180370966 - LIND; Kenneth Egnard ; et al. | 2018-12-27 |
| Pharmaceutical Composition And Application Thereof App 20180271849 - GE; Chuansheng ; et al. | 2018-09-27 |
| Heterobicyclic sphingosine 1-phosphate analogs Grant 10,081,646 - Caldwell , et al. September 25, 2 | 2018-09-25 |
| Heterocyclic compounds useful as PDK1 inhibitors Grant 10,030,016 - Arndt , et al. July 24, 2 | 2018-07-24 |
| Methods of treatment using pyridinonyl PDK1 inhibitors Grant 9,873,693 - Lind , et al. January 23, 2 | 2018-01-23 |
| Heterobicyclic Sphingosine 1-phosphate Analogs App 20180002356 - Caldwell; Richard D. ; et al. | 2018-01-04 |
| Isoindoline Derivative, Intermediate, Preparation Method, Pharmaceutical Composition And Use Thereof App 20170313676 - GE; Chuansheng ; et al. | 2017-11-02 |
| Heterobicyclic sphingosine 1-phosphate analogs Grant 9,708,353 - Caldwell , et al. July 18, 2 | 2017-07-18 |
| Heterocyclic compounds useful as PDK1 inhibitors Grant 9,546,165 - Arndt , et al. January 17, 2 | 2017-01-17 |
| Heterocyclic Compounds Useful As Pdk1 Inhibitors App 20160331756 - Arndt; Joseph ; et al. | 2016-11-17 |
| Heterobicyclic sphingosine 1-phosphate analogs Grant 9,181,191 - Caldwell , et al. November 10, 2 | 2015-11-10 |
| Heterobicyclic Sphingosine 1-phosphate Analogs App 20150232492 - Caldwell; Richard D. ; et al. | 2015-08-20 |
| Pyridinonyl Pdk1 Inhibitors App 20150018351 - Lind; Kenneth Egnard ; et al. | 2015-01-15 |
| Pyridinonyl PDK1 inhibitors Grant 8,778,977 - Lind , et al. July 15, 2 | 2014-07-15 |
| Heterobicyclic sphingosine 1-phosphate analogs App 20140100195 - Caldwell; Richard D. ; et al. | 2014-04-10 |
| Bicyclic aryl sphingosine 1-phosphate analogs Grant 8,546,359 - Caldwell , et al. October 1, 2 | 2013-10-01 |
| Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20130059821 - Caldwell; Richard D. ; et al. | 2013-03-07 |
| Heterobicyclic sphingosine 1-phosphate analogs Grant 8,349,849 - Caldwell , et al. January 8, 2 | 2013-01-08 |
| Bicyclic aryl sphingosine 1-phosphate analogs Grant 8,269,043 - Caldwell , et al. September 18, 2 | 2012-09-18 |
| Heterocyclic Compounds Useful As Pdk1 Inhibitors App 20120208819 - Arndt; Joseph ; et al. | 2012-08-16 |
| Transforming Growth Factor Modulators App 20100166819 - Lee; Wen-Cherng ; et al. | 2010-07-01 |
| Bicyclic aryl sphingosine 1-phosphate analogs App 20100160258 - Caldwell; Richard D. ; et al. | 2010-06-24 |
| Heterobicyclic sphingosine 1-phosphate analogs App 20100160357 - Caldwell; Richard D. ; et al. | 2010-06-24 |
| Pyridinonyl Pdk1 Inhibitors App 20100144730 - Lind; Kenneth Egnard ; et al. | 2010-06-10 |
| Furanone Compounds and Methods of Making and Using The Same App 20100105714 - Sun; Lihong ; et al. | 2010-04-29 |
| Pyrazolopyridines and methods of making and using the same Grant 7,691,865 - Lee , et al. April 6, 2 | 2010-04-06 |
| Substituted Pyrazalones App 20100056505 - Lee; Wen-Cherng ; et al. | 2010-03-04 |
| Imidazolone Compounds and Methods of Making and Using the Same App 20100035918 - Guckian; Kevin ; et al. | 2010-02-11 |
| Tri-substituted heteroaryls and methods of making and using the same Grant 7,612,094 - Lee , et al. November 3, 2 | 2009-11-03 |
| Pyrimidinylpyrazoles as Tgf-Beta Inhibitors App 20080171755 - Lee; Wen-Cherng ; et al. | 2008-07-17 |
| Cell adhesion inhibitors Grant 7,196,112 - Lee , et al. March 27, 2 | 2007-03-27 |
| Cell adhesion inhibitors App 20070066533 - Lee; Wen-Cherng ; et al. | 2007-03-22 |
| Pyrazoles and methods of making and using the same App 20060264440 - Lee; Wen-Cherng ; et al. | 2006-11-23 |
| Cell adhesion inhibitors App 20060166961 - Scott; Daniel ; et al. | 2006-07-27 |
| Cell adhesion inhibitors App 20060166866 - Adams; Steven P. ; et al. | 2006-07-27 |
| Imidazolopyridines and methods of making and using the same App 20060135517 - Lee; Wen-Cherng ; et al. | 2006-06-22 |
| Pyrazolopyridines and methods of making and using the same App 20060106033 - Lee; Wen-Cherng ; et al. | 2006-05-18 |
| Cell adhesion inhibitors Grant 7,034,043 - Scott , et al. April 25, 2 | 2006-04-25 |
| Tri-substituted heteroaryls and methods of making and using the same App 20060063809 - Lee; Wen-Cherng ; et al. | 2006-03-23 |
| Cell adhesion inhibitors Grant 7,001,921 - Adams , et al. February 21, 2 | 2006-02-21 |
| Cell adhesion inhibitors App 20060014966 - Lee; Wen-Cherng ; et al. | 2006-01-19 |
| Cell adhesion inhibitors Grant 6,875,743 - Lin , et al. April 5, 2 | 2005-04-05 |
| Cell adhesion inhibitors App 20040132809 - Scott, Daniel ; et al. | 2004-07-08 |
| Cell adhesion inhibitors Grant 6,630,512 - Adams , et al. October 7, 2 | 2003-10-07 |
| Cell adhesion inhibitors Grant 6,630,503 - Scott , et al. October 7, 2 | 2003-10-07 |
| Cell adhesion inhibitors Grant 6,624,152 - Adams , et al. September 23, 2 | 2003-09-23 |
| Cell adhesion inhibitors Grant 6,596,687 - Lin , et al. July 22, 2 | 2003-07-22 |
| Cell adhesion inhibitors App 20030083267 - Adams, Steven P. ; et al. | 2003-05-01 |
| Cell adhesion inhibitors App 20030018016 - Adams, Steven P. ; et al. | 2003-01-23 |
| VLA-4 inhibitor: oMePUPA-V Grant 6,495,525 - Lee , et al. December 17, 2 | 2002-12-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 